[Federal Register: December 21, 2004 (Volume 69, Number 244)]
[Notices]               
[Page 76478]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21de04-66]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

 
Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--American Association of Blood Banks

    Notice is hereby given that, on September 15, 2004, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), American Association of 
Blood Banks (``AABB'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
(1) the name and principal place of business of the standards 
development organization and (2) the nature and scope of its standards 
development activities. The notifications were filed for the purpose of 
invoking the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances.
    Pursuant to Section 6(b) of the Act, the name and principal place 
of business of the standards development organization is: American 
Association of Blood Banks, Bethesda, MD. The nature and scope of 
AABB's standards development activities are: The development of 
standards for voluntary compliance, and accreditation against those 
standards, in the areas of whole blood and blood component collection, 
processing and transfusion; the collection, processing and 
transplantation of marrow, peripheral blood and umbilical cord blood 
progenitor cells; tissue transplantation, and parentage testing.

Dorothy B. Fountain,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 04-27871 Filed 12-20-04; 8:45 am]

BILLING CODE 4410-11-M